Active Pharmaceutical Ingredient API News and Research

RSS

KHN’s ‘What the Health?’: Pause and effect on Covid vaccines

The effort to vaccinate Americans against covid-19 took a hit this week. The Centers for Disease Control and Prevention and the Food and Drug Administration jointly called for a pause in use of the vaccine made by Johnson & Johnson while experts try to figure out whether it is responsible for a small number of serious blood clots, mostly in women of childbearing age.

17 Apr 2021

Linkam FDCS196 stage used in research to develop a novel transdermal delivery system for risperidone

The first study of its kind reports on the enhancement of skin permeability of risperidone (RIS) using eutectic systems.

From Linkam Scientific Instruments 14 Apr 2021

COVID-19: Several 'proxy wars' spawned by the pandemic

When Australia, India, Japan and the US — countries strategically allied under the so-called Quad (Quadrilateral Security Dialogue) — switched focus to fighting COVID-19, it was seen as one more of the several 'proxy wars' spawned by the pandemic.

1 Apr 2021

KHN’s ‘What the Health?’: Planning for round two

Congress is out of session, but that hasn't stopped Democrats from planning their next round of health legislation.

1 Apr 2021

FDA acknowledged receipt of ORNL’s cancer-fighting Ac-225 isotope

A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.

27 Mar 2021

KHN’s ‘What the Health?’: Getting down to work at HHS

As questions swirl about the Covid vaccine made by AstraZeneca, public health experts are worried the confusion could create more doubts among people already hesitant to get a vaccine.

25 Mar 2021

KHN’s ‘What the Health?’: ACA packs more benefits — and more confusion

The Covid relief bill signed by President Joe Biden a week ago includes billions of dollars in new health benefits for consumers. But those benefits may be hard for people to take advantage of because of the interaction with the income tax system and the lack of experts to help them navigate the system.

18 Mar 2021

CAS Common Chemistry now provides authoritative data on almost 500,000 substances

CAS, a division of the American Chemical Society (ACS) that specializes in scientific information solutions, has expanded the CAS Common Chemistry resource.

17 Mar 2021

KHN’s ‘What the Health?’: Expanding the ACA in an unpredicted way

For the first time since its enactment in 2010, the Affordable Care Act is slated for major benefit expansions, courtesy of the covid relief bill approved by Congress this week. But the changes are only temporary, so the measure also tees up a fight to make them permanent.

11 Mar 2021

KHN’s ‘What the Health?’: Good and not-so-good news on Covid

There's good news and bad news on Covid-19 this week. On the one hand, several million doses of the one-shot Johnson & Johnson vaccine authorized by the FDA for emergency use are already going into the arms of people around the nation.

4 Mar 2021

Study: Public attitude toward COVID-19 and its treatments is more “infectious” than disease itself

Public attitude toward COVID-19 and its treatments is more "infectious" than the disease itself, according to a new Northwestern Medicine study using Artificial Intelligence (AI) to analyze tweets about the virus.

2 Mar 2021

‘Into the Covid ICU’: A new doctor bears witness to the isolation, inequities of pandemic

This week marks a grim milestone: Half a million Americans have died of Covid-19. KHN reporter Jenny Gold, in collaboration with Reveal from the Center for Investigative Reporting and PRX, spent eight months following one first-year medical resident working on the front lines of the pandemic.

1 Mar 2021

KHN’s ‘What the health?’: Staffing up at HHS

More than a month into President Joe Biden’s term, nominees to fill some of the top posts at the Department of Health and Human Services are finally getting confirmation hearings in the Senate, starting with the nominee for secretary, California Attorney General Xavier Becerra.

26 Feb 2021

KHN’s ‘What the Health?’: Open enrollment, one more time

An estimated 9 million Americans eligible for free or reduced premium health insurance under the Affordable Care Act have a second chance to sign up for 2021 coverage, since the Biden administration reopened enrollment on healthcare.gov and states that run their own marketplaces followed suit.

18 Feb 2021

Taking Advantage of Measuring Molecular Collisional Cross-Sections in Pharma

News-Medical talks to Mike Greig, Director of Pharma at Bruker, about why measuring collisional cross-sections is beneficial to developing new drugs.

From Bruker Life Sciences Mass Spectrometry 10 Feb 2021

Research could pave way for injectable gels that release drugs over time

Gels are formed by mixing polymers into fluids to create gooey substances useful for everything from holding hair in place to enabling contact lenses to float over the eye.

4 Feb 2021

KHN’s ‘What the Health?’: Covid and kids

Nearly a year into the pandemic, many public schools are still closed to in-person instruction. But while there is increasing evidence that schools are not a major source of infection, teachers and staffers remain concerned about going back to class before they are vaccinated.

4 Feb 2021

KHN’s ‘What the Health?’: The long road to unwinding Trump health policies

Thursday was "health day" in President Joe Biden's sprint to launch his presidency, and he signed two executive orders addressing health coverage and women's reproductive rights.

28 Jan 2021

KHN’s ‘What the Health?’: The Biden health agenda

President Joe Biden wasted no time getting down to work. Among the raft of executive orders he signed on Inauguration Day were several aimed at curtailing the covid crisis, including one requiring mask-wearing by federal employees and anyone on federal property for the next 100 days.

21 Jan 2021